Septerna, Inc. (SEPN)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$47.35-1.11%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · SEPN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | 98.9 | 46.0 | 1.1 | 0.2 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 120.8 | 97.6 | 65.3 | 36.0 | — |
| Operating Income | (43.5) | (68.3) | (80.8) | 2.1 | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 20.7 | 19.5 | 8.6 | 2.8 | — |
| Other Non-Operating Income / Expenses | 20.6 | 19.4 | 8.5 | 2.8 | — |
| EBT, Incl. Unusual Items | (22.9) | (48.9) | (72.3) | (48.9) | — |
| Income Tax Expense | — | 0.0 | (0.5) | 0.7 | — |
| Net Income | |||||
| Net Income | (24.2) | (48.9) | (71.8) | 4.2 | — |
| Per Share | |||||
| Basic EPS | (0.54) | (1.10) | (7.26) | 0.29 | — |
| Diluted EPS | (0.54) | (1.10) | (7.26) | 0.29 | — |
| Revenue per Share | 2.20 | — | — | — | — |
| Basic Weighted Avg Shares | 45.0 | 44.3 | 9.9 | 1.9 | — |
| Diluted Weighted Avg Shares | 45.0 | 44.3 | 9.9 | 2.2 | — |
| Supplemental | |||||
| EBITDA | — | (66.7) | (79.4) | 2.9 | — |
| EBIT | (43.5) | (68.3) | (80.8) | 2.1 | — |
| Effective Tax Rate | — | — | — | -1.4% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.